Skip to main content
Premium Trial:

Request an Annual Quote

William Parrett, Jason Novi, Robert Gavin, Wilhelm Lachnit, Tim Harkness

Premium
Thermo Fisher Scientific last week announced the election of William Parrett to its board.
 
Parrett has been appointed to the company’s audit committee.
 
Until his retirement last year, Parrett was at Deloitte Touche Tohmatsu for more than 40 years, most recently as global CEO.
 

 
Cell BioSciences this week announced Jason Novi has joined the company as its CFO. Also, Robert Gavin was named vice president, engineering, and Wilhelm Lachnit was named vice president, R&D.
 
Novi will be responsible for the finance, manufacturing, and administrative functions of the firm. Prior to Cell BioSciences, he was vice president of finance at Nektar Therapeutics. Between 2000 and 2007, he was director of finance at Molecular Devices.

Gavin was most recently director of engineering at MDS Analytical Technologies. Lachnit had most recently been at Molecular Devices where he held both scientific and commercial leadership positions.

Cell BioSciences is a startup nanofluidic systems firm. Last month it named Tim Harkness its president and CEO.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.